Australia, Oct. 14 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘A study of BRD-333 in Healthy Adult Participants’. The following are the other relevant details related to the trial:
Trial ID: 392573
Submit Date: 9/2/26 10:35
Study Type: Interventional
Intervention: Part A Single Ascending Dose (SAD)
Part A will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of a single subcutaneous injection of BRD-333 in healthy adults. A registered nurse will administer the study intervention (BRD-333 or placebo) in the clinical research unit. The planned dose levels are 300mg (cohort 1), 600mg (cohort 2) and 1200mg (cohort 3). Each Part A cohort will dose 2 s...